贝壳创始人因肺癌去世,比吸烟更可怕的,是这种体内“常客”( 三 )


本文插图


doi: 10.1038/s41564-020-00831-6
体内微生物群在肺癌的病理演变中还有哪些作用 , 如何利用它们来防治肺癌 , 是未来基础研究和临床转化的热点 。 相信更多的微生物疗法将给肺癌患者带来福音 。
参考文献:
1、H Dean Hosgood, et al. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers. Thorax. 2021 Mar; 76(3):256-263. doi: 10.1136/thoraxjnl-2020-215542.
2、Jun-Chieh J Tsay, et al. Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discov. 2021 Feb;11(2):293-307. doi: 10.1158/2159-8290.CD-20-0263.
3、Yueqiong Ni, et al. Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. ISME J. 2021 May; doi: 10.1038/s41396-021-00998-8.
4、Se-Hoon Lee, et al. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nat Microbiol. 2021 Mar;6(3):277-288. doi: 10.1038/s41564-020-00831-6.
撰文 | 官水木